![]() (NASDAQ: CLVS) announced that nonclinical data describing the expression of fibroblast activating protein (FAP) in a variety of solid tumor types will be presented during the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, taking place October 7-10, 2021. BOULDER, Colo.-( BUSINESS WIRE)-Clovis Oncology, Inc.
0 Comments
Leave a Reply. |